Nanjing Ying Peng Asset Management

Nanjing Ying Peng Asset Management is a professional investment institution based in China that focuses primarily on the healthcare and life sciences industries. Founded in 2015, the firm manages several healthcare-dedicated private equity funds, targeting high-growth sectors such as innovative biopharmaceuticals, high-end medical devices, and specialized medical services. Nanjing Ying Peng plays a significant role in the Chinese biotech ecosystem by providing growth capital and strategic guidance to early and growth-stage companies. Their investment strategy emphasizes technological innovation and clinical unmet needs, often participating in significant financing rounds for domestic biotech leaders. The firm is recognized for its deep industry expertise and its role in facilitating cross-border collaborations and M&A activities within the medical sector.